Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02

Por Lee, Eudocia Q., Kuhn, John, Lamborn, Kathleen R., Abrey, Lauren, DeAngelis, Lisa M., Lieberman, Frank, Robins, H. Ian, Chang, Susan M., Yung, W. K. Alfred, Drappatz, Jan, Mehta, Minesh P., Levin, Victor A., Aldape, Kenneth, Dancey, Janet E., Wright, John J., Prados, Michael D., Cloughesy, Timothy F., Gilbert, Mark R., Wen, Patrick Y.
Publicado em 2012

A Phase 1 Pharmacokinetic Optimal Dosing Study of Intraventricular Topotecan for Children with Neoplastic Meningitis: A Pediatric Brain Tumor Consortium Study

Por Blaney, Susan M., Tagen, Michael, Onar-Thomas, Arzu, Berg, Stacey L., Gururangan, Sri, Scorsone, Kathleen, Su, Jack, Goldman, Stewart, Kieran, Mark W., Kun, Larry, Boyett, Jim, Stewart, Clinton
Publicado em 2012

Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02

Por Wen, Patrick Y., Chang, Susan M., Lamborn, Kathleen R., Kuhn, John G., Norden, Andrew D., Cloughesy, Timothy F., Robins, H. Ian, Lieberman, Frank S., Gilbert, Mark R., Mehta, Minesh P., Drappatz, Jan, Groves, Morris D., Santagata, Sandro, Ligon, Azra H., Yung, W.K. Alfred, Wright, John J., Dancey, Janet, Aldape, Kenneth D., Prados, Michael D., Ligon, Keith L.
Publicado em 2014

Phase I Trial of Weekly MK-0752 in Children with Refractory Central Nervous System Malignancies: A Pediatric Brain Tumor Consortium Study

Por Hoffman, Lindsey M., Fouladi, Maryam, Olson, James, Daryani, Vinay M., Stewart, Clinton F., Wetmore, Cynthia, Kocak, Mehmet, Onar-Thomas, Arzu, Wagner, Lars, Gururangan, Sridharan, Packer, Roger J., Blaney, Susan M., Gajjar, Amar, Kun, Larry E., Boyett, James M., Gilbertson, Richard J.
Publicado no Childs Nerv Syst (2015)

PDCT-12. A PHASE I TRIAL OF TUMOR TREATING FIELDS WITH AND WITHOUT CONCOMITANT TEMOZOLOMIDE...

Por Hanson, Derek
Publicado no Neuro Oncol (2018)

Blockade of Type I Interferon (IFN) Production by Retroviral Replicating Vectors and Reduced Tumor Cell Responses to IFN Likely Contribute To Tumor Selectivity

Por Lin, Amy H., Burrascano, Cindy, Pettersson, Par L., Ibañez, Carlos E., Gruber, Harry E., Jolly, Douglas J.
Publicado em 2014

Expression of NR1I3 in mouse lung tumors induced by the tobacco-specific nitrosamine 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanone

Por Fukumasu, H., Cordeiro, Y.G., Rochetti, A.L., Barra, C.N., Sámora, T.S., Strefezzi, R.F., Dagli, M.L.Z.
Publicado no Braz J Med Biol Res (2015)

Choindroitinase ABC I-mediated enhancement of oncolytic virus spread and anti tumor efficacy

Por Dmitrieva, Nina, Yu, Lianbo, Viapiano, Mariano, Cripe, Timothy P, Chiocca, EA, Glorioso, J, Kaur, Balveen
Publicado em 2010

First Report of Tumor Treating Fields (TTFields) Therapy for Glioblastoma in Comorbidity with Multiple Sclerosis

Por Rebecca Kassubek, René Mathieu
Publicado em 2022-04-01

Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma

Por Kieran, Mark W, Chisholm, Julia, Casanova, Michela, Brandes, Alba A, Aerts, Isabelle, Bouffet, Eric, Bailey, Simon, Leary, Sarah, MacDonald, Tobey J, Mechinaud, Francoise, Cohen, Kenneth J, Riccardi, Riccardo, Mason, Warren, Hargrave, Darren, Kalambakas, Stacey, Deshpande, Priya, Tai, Feng, Hurh, Eunju, Geoerger, Birgit
Publicado no Neuro Oncol (2017)

Recurrent Glioblastoma Treated with Bevacizumab: Contrast-enhanced T1-weighted Subtraction Maps...

Por Ellingson, Benjamin M., Kim, Hyun J., Woodworth, Davis C., Pope, Whitney B., Cloughesy, Jonathan N., Harris, Robert J., Lai, Albert, Nghiemphu, Phioanh L., Cloughesy, Timothy F.
Publicado no Radiology (2014)

TMIC-34. Na/H EXCHANGER ISOFORM 1 (NHE1) IN IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT IN MOUSE SYNGENEIC GLIOMA MODEL

Por Hasan, Nabiul, Guan, Xiudong, Kohanbash, Gary, Sun, Dandan
Publicado no Neuro Oncol (2018)

ReACT Phase II trial: a critical evaluation of the use of rindopepimut plus bevacizumab to treat EGFRvIII-positive recurrent glioblastoma

Por Gatson, Na Tosha N, Weathers, Shiao-Pei S, de Groot, John F
Publicado no CNS Oncol (2016)

Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy

Por Mehmet Asim Bilen, Julie M. Shabto, Dylan J. Martini, Yuan Liu, Colleen Lewis, Hannah Collins, Mehmet Akce, Haydn Kissick, Bradley C. Carthon, Walid L. Shaib, Olatunji B. Alese, Conor E. Steuer, Christina Wu, David H. Lawson, Ragini Kudchadkar, Viraj A. Master, Bassel El-Rayes, Suresh S. Ramalingam, Taofeek K. Owonikoko, R. Donald Harvey
Publicado em 2019-08-01

O7.08 ONE-STOP SHOPPING IN BRAIN TUMOR IMAGING: INITIAL EXPERIENCE WITH PET/MR FOR SIMULTANEOUS...

Por Henriksen, O.M., Larsen, V.A., Muhic, A., Hansen, A.E., Larsson, H.B.W., Poulsen, H.S., Law, I.
Publicado em 2014

FasL and FADD delivery by a glioma-specific and cell cycle-dependent HSV-1 amplicon virus enhanced apoptosis in primary human brain tumors

Por Ho, Ivy A, Ng, Wai H, Lam, Paula Y
Publicado em 2010

NT-16 NANOPARTICLE-MEDIATED DELIVERY OF ANTI-Ape1 siRNA SENSITIZES PEDIATRIC BRAIN TUMOR CELLS TO RADIATION THERAPY BY INHIBITING DNA REPAIR

Por Kievit, Forrest, Stephen, Zachary, Wang, Kui, Dayringer, Christopher, Ellenbogen, Richard, Silber, John, Zhang, Miqin
Publicado em 2014

The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0/G1 arrest and apoptosis

Por Feng, Zhanzhan, Xia, Yong, Gao, Tiantao, Xu, Fuyan, Lei, Qian, Peng, Cuiting, Yang, Yufei, Xue, Qiang, Hu, Xi, Wang, Qianqian, Wang, Ranran, Ran, Zhiqiang, Zeng, Zhilin, Yang, Nan, Xie, Zixin, Yu, Luoting
Publicado no Cell Death Dis (2018)

ANGI-14. EPIGENETIC REACTIVATION OF BAI1 SUPPRESSES TUMOR INVASION BY PREVENTING TGFβ1-INDUCED MESENCHYMAL SWITCH IN GLIOBLASTOMA

Por Osuka, Satoru, Yang, Liquan, Zhu, Dan, Devi, Narra, Van Meir, Erwin
Publicado no Neuro Oncol (2018)

ET-40 ONCOLYTIC VIRUS INDUCED HMGB1 SECRETION AND ITS IMPACT ON TUMOR ANGIOGENESIS

Por Muili, Kamaldeen, Bolyard, Chelsea, Jaime-Ramirez, Cristina, Yoo, Ji Young, Kaur, Balveen
Publicado em 2014